Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Small Cell Lung Carcinoma 156Lung Neoplasms 99Carcinoma, Non-Small-Cell Lung 61Extensive Stage Small Cell Lung Cancer 10Adenocarcinoma of Lung 7Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Small Cell 5Adenocarcinoma, Bronchiolo-Alveolar 5Small Cell Lung Cancer Extensive Stage 4Drug-Related Side Effects and Adverse Reactions 4Small Cell Lung Cancer Limited Stage 3SCLC, Extensive Stage 3SCLC 3Recurrence 3Radiation Injuries 3Neoplasms 3Carcinoma, Ovarian Epithelial 3Thymoma 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2SCLC,Extensive Stage 2Ovarian Neoplasms 2Melanoma 2Limited Stage Small Cell Lung Cancer 2Kidney Neoplasms 2Extensive Small Cell Lung Cancer 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2

Interventions

Etoposide 2Carboplatin 2anlotinib 1Radiotherapy 1Drug Therapy 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Extensive Small Cell Lung Cancer × Etoposide × Thoracic × Clear all
NCT07083375 2025-07-24

QL1706

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
56 enrolled
Thoracic

Extensive Small Cell Lung Cancer

NCT04234607 2020-01-22

A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3 Unknown
738 enrolled
Thoracic

Extensive Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡